Paul Datlinger

Paul DatlingerPaul Datlinger
PD

Paul Datlinger

Associate Director, Genome Editing

About

Paul Datlinger is an Associate Director of Genome Editing at Arc Technology Centers. He invented CROP-seq for single-cell CRISPR screens and scifi-RNA-seq for high-throughput profiling. He received his Ph.D. in Molecular Medicine from the University of Vienna, Austria, and has led teams in academia and industry, including CeMM, Illumina AI Lab, and Xaira Therapeutics. His group is part of Arc's Virtual Cell Initiative, focusing on building single-cell screens for a Virtual Cell model with a special emphasis on T cell engineering.
Frequently asked

Who is Paul Datlinger?

Paul Datlinger is an Associate Director of Genome Editing at Arc Technology Centers. He invented CROP-seq for single-cell CRISPR screens and scifi-RNA-seq for high-throughput profiling. He received his Ph.D. in Molecular Medicine from the University of Vienna, Austria, and has led teams in academia and industry, including CeMM, Illumina AI Lab, and Xaira Therapeutics. His group is part of Arc's Vi…

What is Paul Datlinger's current role?

Paul Datlinger is currently Associate Director, Genome Editing.

Comments

No comments yet. Be the first to share your take.

Profile

About Paul Datlinger

Paul Datlinger is Associate Director, Genome Editing. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.